Company intelligence / Profile preview

Pharmocann Global Ltd

Ownership
Private
Development stage
Commercial
01

Overview

The company develops non-invasive and non-medicinal solutions to improve blood flow processes using pneumatic devices. They also develop and produce medical cannabis in Israel.

Therapeutic areas
Cardiovascular
Modalities
Medical cannabisNon-invasive medical devices
Industry
Biotech
02

Drug pipeline

1 asset

hydrogel

Commercial
Indications
Pain, Dermatological diseases, Inflammatory bowel disease
03

Partnerships

Queensland Bauxite Ltd (ASX:QBL)

Beyond the preview

Go deeper on Pharmocann Global Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmocann Global Ltd.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call